LH Logo

Laboratory Corporation of America Holdings (LH) 

NYSE
Market Cap
$19.57B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
338 of 776
Rank in Industry
18 of 42

Largest Insider Buys in Sector

LH Stock Price History Chart

LH Stock Performance

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C …

Insider Activity of Laboratory Corporation of America Holdings

Over the last 12 months, insiders at Laboratory Corporation of America Holdings have bought $0 and sold $20.16M worth of Laboratory Corporation of America Holdings stock.

On average, over the past 5 years, insiders at Laboratory Corporation of America Holdings have bought $1.04M and sold $14.93M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 44 shares for transaction amount of $10,251 was made by Caveney Brian J (EVP, President of Diagnostics) on 2022‑09‑07.

List of Insider Buy and Sell Transactions, Laboratory Corporation of America Holdings

2024-10-24Saledirector
1,000
0.0012%
$230.00$230,0000.00%
2024-08-19SaleEVP, Chief Legal Officer
2,000
0.0024%
$227.05$454,100-0.69%
2024-08-15SaleChief Financial Officer, EVP
15,000
0.0179%
$223.99$3.36M0.00%
2024-08-08Saledirector
586
0.0007%
$225.00$131,850-0.04%
2024-08-07Saledirector
414
0.0005%
$225.00$93,150+2.44%
2024-08-05SaleEVP, CIO & CTO
12,093
0.0144%
$229.10$2.77M-1.68%
2024-05-14SaleEVP, Chief Legal Officer
2,000
0.0024%
$210.83$421,655+2.46%
2024-05-02Saledirector
250
0.0003%
$200.10$50,025+7.66%
2024-04-30Saledirector
250
0.0003%
$204.13$51,034+6.83%
2024-04-29SaleSVP, Chief Accounting Officer
2,439
0.0029%
$204.33$498,358+5.31%
2024-04-01SaleEVP, Pres Diagnostics & COO
6,477
0.0077%
$217.29$1.41M-2.01%
2024-04-01SaleEVP, Chief Marketing Officer
3,500
0.0042%
$217.29$760,515-2.01%
2024-03-28SaleEVP, Chief Legal Officer
3,553
0.0042%
$216.74$770,077-2.94%
2024-03-07SaleEVP, Pres Diagnostics & COO
5,048
0.006%
$218.45$1.1M-2.71%
2024-03-07SaleEVP, Chief Marketing Officer
227
0.0003%
$218.45$49,588-2.71%
2024-02-21SaleChief Financial Officer, EVP
34,504
0.0403%
$215.97$7.45M-1.92%
2024-02-21SaleEVP, Pres, Central Labs & Intl
500
0.0006%
$215.49$107,745-1.92%
2024-02-13SaleEVP, Chief Legal Officer
237
0.0003%
$226.45$53,669-3.96%
2024-02-08SaleEVP, Chief Legal Officer
259
0.0003%
$222.06$57,514-3.59%
2024-02-05SaleEVP, Chief Legal Officer
193
0.0002%
$220.57$42,570-2.12%

Insider Historical Profitability

6.28%
LANE WENDY Edirector
17395
0.0208%
$233.9818+3.62%
Caveney Brian JEVP, President of Diagnostics
14282
0.0171%
$233.9820<0.0001%
NEUPERT PETER Mdirector
10254
0.0123%
$233.9810<0.0001%
Conrad Andrew JEVP, Chief Scientific Officer
6100
0.0073%
$233.9811+19.38%
Watson Craig Mdirector
1288
0.0015%
$233.9816+22.07%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$2.11B11.439.64M-1.12%-$23.87M0.04
BlackRock$2.06B11.199.43M-10.06%-$230.42M0.05
State Street$804.73M4.373.68M-2.3%-$18.93M0.03
Wellington Management Company$487.81M2.652.23M-0.67%-$3.31M0.08
Geode Capital Management$419.88M2.291.93M+3.03%+$12.36M0.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.